Driven Brands Q2 FY26 net income from continuing operations more than doubled to $37.3 million; revenue rises 6.8% to $507.4 million
Reuters2026/08/06 11:20Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
- Driven Brands posted Q2 revenue of USD 507.4 million, up 6.8% year over year, with same-store sales up 1.4%.
- Net income from continuing operations rose to USD 37.3 million, or USD 0.23 per diluted share.
- GAAP adjusted EBITDA fell 7% to USD 107 million, including USD 11.8 million of non-recurring restatement-related costs.
- System-wide sales increased 5% to USD 1.6 billion, driven by a 1% same-store sales gain and a 5% increase in store count.
- Reiterated FY2026 outlook: revenue of about USD 1.95-2.05 billion, adjusted EBITDA of about USD 430-460 million, adjusted diluted EPS of about USD 1.15-1.25.
Disclaimer:
This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Driven Brands Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001804745-26-000072), on August 06, 2026, and is solely responsible for the information contained therein.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Descartes Q2 Tops Expectations as Acquisitions, AI Investments Support Growth, RBC Says
MT newswire•2026/09/11 15:34
Oncoclínicas corrects filing, says arbitration request was submitted Aug. 21, not yet initiated
Reuters•2026/09/11 15:33
Definium Therapeutics' Upcoming Phase 3 Data on DT120 to De-Risk Program, Back FDA Approval, RBC Says
MT newswire•2026/09/11 15:33
Crypto prices
MoreBitcoin
BTC
$78,623.09
+1.96%
Ethereum
ETH
$2,609
+7.12%
Tether USDt
USDT
$0.9998
+0.02%
BNB
BNB
$739.33
+4.45%
XRP
XRP
$1.4
+3.26%
USDC
USDC
$0.9999
+0.01%
Solana
SOL
$103.25
+3.63%
TRON
TRX
$0.3363
-0.76%
Hyperliquid
HYPE
$83.27
+3.34%
Zcash
ZEC
$1,198.57
+2.56%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now